Reference
Wakuda K, et al. Efficacy of second-line chemotherapy in poor-risk patients with refractory-relapsed small-cell lung cancer. Japanese Journal of Clinical Oncology 48: 822-826, No. 9, 2018. Available from: URL: http://doi.org/10.1093/jjco/hyy107 - Japan
Rights and permissions
About this article
Cite this article
Amrubicin. Reactions Weekly 1733, 43 (2018). https://doi.org/10.1007/s40278-018-55842-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-55842-3